New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2012-01-24

AUTHORS

Michael Maes, Zdenĕk Fišar, Miguel Medina, Giovanni Scapagnini, Gabriel Nowak, Michael Berk

ABSTRACT

This paper reviews new drug targets in the treatment of depression and new drug candidates to treat depression. Depression is characterized by aberrations in six intertwined pathways: (1) inflammatory pathways as indicated by increased levels of proinflammatory cytokines, e.g. interleukin-1 (IL-1), IL-6, and tumour necrosis factor α. (2) Activation of cell-mediated immune pathways as indicated by an increased production of interferon γ and neopterin. (3) Increased reactive oxygen and nitrogen species and damage by oxidative and nitrosative stress (O&NS), including lipid peroxidation, damage to DNA, proteins and mitochondria. (4) Lowered levels of key antioxidants, such as coenzyme Q10, zinc, vitamin E, glutathione, and glutathione peroxidase. (5) Damage to mitochondria and mitochondrial DNA and reduced activity of respiratory chain enzymes and adenosine triphosphate production. (6) Neuroprogression, which is the progressive process of neurodegeneration, apoptosis, and reduced neurogenesis and neuronal plasticity, phenomena that are probably caused by inflammation and O&NS. Antidepressants tend to normalize the above six pathways. Targeting these pathways has the potential to yield antidepressant effects, e.g. using cytokine antagonists, minocycline, Cox-2 inhibitors, statins, acetylsalicylic acid, ketamine, ω3 poly-unsaturated fatty acids, antioxidants, and neurotrophic factors. These six pathways offer new, pathophysiologically guided drug targets suggesting that novel therapies could be developed that target these six pathways simultaneously. Both nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activators and glycogen synthase kinase-3 (GSK-3) inhibitors target the six above-mentioned pathways. GSK-3 inhibitors have antidepressant effects in animal models of depression. Nrf2 activators and GSK-3 inhibitors have the potential to be advanced to phase-2 clinical trials to examine whether they augment the efficacy of antidepressants or are useful as monotherapy. More... »

PAGES

127-150

References to SciGraph publications

  • 2009-12. Agomelatine in CNS DRUGS
  • 2007-01. Mitochondrial Dysfunction as the Molecular Basis of Bipolar Disorder in CNS DRUGS
  • 2007-02-01. Venlafaxine Modulates Depression-Induced Oxidative Stress in Brain and Medulla of Rat in NEUROCHEMICAL RESEARCH
  • 2006-10-25. Effect of Electroconvulsive Shock on Mitochondrial Respiratory Chain in Rat Brain in NEUROCHEMICAL RESEARCH
  • 1999. Anhedonic and Anxiogenic Effects of Cytokine Exposure in CYTOKINES, STRESS, AND DEPRESSION
  • 2009-07-03. Neuron differentiation and neuritogenesis stimulated by N-acetylcysteine (NAC) in ACTA PHARMACOLOGICA SINICA
  • 2005-07-12. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research in MOLECULAR PSYCHIATRY
  • 1996-09. Mitochondrial involvement in schizophrenia and other functional psychoses in NEUROCHEMICAL RESEARCH
  • 2009-01-16. Intestinal permeability in the pathogenesis of NSAID-induced enteropathy in JOURNAL OF GASTROENTEROLOGY
  • 2009-05. Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment in PHARMACOLOGICAL REPORTS
  • 2010. Therapeutic Potential of Dietary Polyphenols against Brain Ageing and Neurodegenerative Disorders in BIO-FARMS FOR NUTRACEUTICALS
  • 1999-04. Negative Immunoregulatory Effects of Antidepressants: Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion in NEUROPSYCHOPHARMACOLOGY
  • 2007-03-31. Protective Effects of Lamotrigine, Aripiprazole and Escitalopram on Depression-induced Oxidative Stress in Rat Brain in NEUROCHEMICAL RESEARCH
  • 2010-12-01. The Effects of Antidepressants on Mitochondrial Function in a Model Cell System and Isolated Mitochondria in NEUROCHEMICAL RESEARCH
  • 2007-05-18. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? in CELLULAR AND MOLECULAR LIFE SCIENCES
  • 2008-01-30. Mitochondrially Mediated Plasticity in the Pathophysiology and Treatment of Bipolar Disorder in NEUROPSYCHOPHARMACOLOGY
  • 2005-07-10. Toll-like receptor–mediated cytokine production is differentially regulated by glycogen synthase kinase 3 in NATURE IMMUNOLOGY
  • 1999-03-17. Anti-bipolar therapy: mechanism of action of lithium in MOLECULAR PSYCHIATRY
  • 2003-06-01. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse in NATURE NEUROSCIENCE
  • 2007-03-31. Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression in JOURNAL OF NEURAL TRANSMISSION
  • 2011-03-30. Protective effects of resveratrol on calcium-induced oxidative stress in rat heart mitochondria in JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
  • 2011-12-20. Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals in MOLECULAR PSYCHIATRY
  • 2007-03-24. Glycogen synthase kinase-3β inhibition attenuates the development of ischaemia/reperfusion injury of the gut in INTENSIVE CARE MEDICINE
  • 2011-04-19. Modulation of Nrf2/ARE Pathway by Food Polyphenols: A Nutritional Neuroprotective Strategy for Cognitive and Neurodegenerative Disorders in MOLECULAR NEUROBIOLOGY
  • 2011-07-27. The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis in NEUROPSYCHOPHARMACOLOGY
  • 2006-02-21. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine in MOLECULAR PSYCHIATRY
  • 2005-04-13. Glycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs in NEUROPSYCHOPHARMACOLOGY
  • 2008-12-16. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression in METABOLIC BRAIN DISEASE
  • 2004-12. Stress, cognitive impairment and cell adhesion molecules in NATURE REVIEWS NEUROSCIENCE
  • 2000-07. Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation in NATURE
  • 2000-04. Cytokine Production and Treatment Response in Major Depressive Disorder in NEUROPSYCHOPHARMACOLOGY
  • 2008-02-22. Symptoms of somatization as a rapid screening tool for mitochondrial dysfunction in depression in BIOPSYCHOSOCIAL MEDICINE
  • 2004-10-27. Low plasma vitamin E levels in major depression: diet or disease? in EUROPEAN JOURNAL OF CLINICAL NUTRITION
  • 2011-08-11. Depletion of Nrf2 Enhances Inflammation Induced by Oxyhemoglobin in Cultured Mice Astrocytes in NEUROCHEMICAL RESEARCH
  • 2004-03-24. In Vivo Regulation of Glycogen Synthase Kinase-3β (GSK3β) by Serotonergic Activity in Mouse Brain in NEUROPSYCHOPHARMACOLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s10787-011-0111-7

    DOI

    http://dx.doi.org/10.1007/s10787-011-0111-7

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1025174834

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/22271002


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Pharmacology and Pharmaceutical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antioxidants", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Depression", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Disease Progression", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Delivery Systems", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glycogen Synthase Kinase 3", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunity, Cellular", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Inflammation Mediators", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mitochondria", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "NF-E2-Related Factor 2", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Nitrosation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Oxidative Stress", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Maes Clinics@TRIA, 998 Rimklongsamsen Road, 10310, Bangkok, Thailand", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Maes Clinics@TRIA, 998 Rimklongsamsen Road, 10310, Bangkok, Thailand"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Maes", 
            "givenName": "Michael", 
            "id": "sg:person.012515577577.25", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012515577577.25"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Psychiatry, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic", 
              "id": "http://www.grid.ac/institutes/grid.411798.2", 
              "name": [
                "Department of Psychiatry, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Fi\u0161ar", 
            "givenName": "Zden\u0115k", 
            "id": "sg:person.0575473643.42", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0575473643.42"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Noscira, Tres Cantos, Spain", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Noscira, Tres Cantos, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Medina", 
            "givenName": "Miguel", 
            "id": "sg:person.01255705374.56", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255705374.56"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Health Sciences, University of Molise, Campobasso, Italy", 
              "id": "http://www.grid.ac/institutes/grid.10373.36", 
              "name": [
                "Department of Health Sciences, University of Molise, Campobasso, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Scapagnini", 
            "givenName": "Giovanni", 
            "id": "sg:person.0772116134.66", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772116134.66"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pharmacobiology, Jagiellonian University Medical College, Institute of Pharmacology PAS, Krakow, Poland", 
              "id": "http://www.grid.ac/institutes/grid.5522.0", 
              "name": [
                "Department of Pharmacobiology, Jagiellonian University Medical College, Institute of Pharmacology PAS, Krakow, Poland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nowak", 
            "givenName": "Gabriel", 
            "id": "sg:person.01163140663.73", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163140663.73"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Mental Health Research Institute, Melbourne, Australia", 
              "id": "http://www.grid.ac/institutes/grid.415325.4", 
              "name": [
                "Department of Clinical and Biomedical Sciences, The University of Melbourne, Melbourne, VIC, Australia", 
                "Orygen Research Centre, Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, Australia", 
                "Mental Health Research Institute, Melbourne, Australia"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Berk", 
            "givenName": "Michael", 
            "id": "sg:person.01257261765.73", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257261765.73"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.2165/00023210-200721010-00001", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022297507", 
              "https://doi.org/10.2165/00023210-200721010-00001"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/npp.2011.132", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045237385", 
              "https://doi.org/10.1038/npp.2011.132"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00535-008-2266-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048185237", 
              "https://doi.org/10.1007/s00535-008-2266-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.npp.1300731", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046403978", 
              "https://doi.org/10.1038/sj.npp.1300731"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1016/s0893-133x(99)00134-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007198609", 
              "https://doi.org/10.1016/s0893-133x(99)00134-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12035-011-8181-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034451897", 
              "https://doi.org/10.1007/s12035-011-8181-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/mp.2011.167", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023005430", 
              "https://doi.org/10.1038/mp.2011.167"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11064-010-0331-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046900819", 
              "https://doi.org/10.1007/s11064-010-0331-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.mp.4001711", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047482815", 
              "https://doi.org/10.1038/sj.mp.4001711"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11064-011-0571-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043113915", 
              "https://doi.org/10.1007/s11064-011-0571-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10863-011-9349-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008210266", 
              "https://doi.org/10.1007/s10863-011-9349-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.mp.4001805", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024644463", 
              "https://doi.org/10.1038/sj.mp.4001805"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11064-006-9258-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005583383", 
              "https://doi.org/10.1007/s11064-006-9258-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.mp.4000494", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024877376", 
              "https://doi.org/10.1038/sj.mp.4000494"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00702-007-0705-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025211480", 
              "https://doi.org/10.1007/s00702-007-0705-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nn1069", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017871287", 
              "https://doi.org/10.1038/nn1069"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00134-007-0595-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002017190", 
              "https://doi.org/10.1007/s00134-007-0595-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02532409", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012282090", 
              "https://doi.org/10.1007/bf02532409"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-0-585-37970-8_12", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051824596", 
              "https://doi.org/10.1007/978-0-585-37970-8_12"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00018-007-7079-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003536562", 
              "https://doi.org/10.1007/s00018-007-7079-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1016/s1734-1140(09)70084-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021803075", 
              "https://doi.org/10.1016/s1734-1140(09)70084-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.npp.1301671", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049219951", 
              "https://doi.org/10.1038/sj.npp.1301671"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/11318640-000000000-00000", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048198006", 
              "https://doi.org/10.2165/11318640-000000000-00000"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ni1221", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034883080", 
              "https://doi.org/10.1038/ni1221"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/aps.2009.72", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008490105", 
              "https://doi.org/10.1038/aps.2009.72"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1751-0759-2-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017318313", 
              "https://doi.org/10.1186/1751-0759-2-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-1-4419-7347-4_3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041698027", 
              "https://doi.org/10.1007/978-1-4419-7347-4_3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrn1555", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020167313", 
              "https://doi.org/10.1038/nrn1555"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11064-006-9185-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045444984", 
              "https://doi.org/10.1007/s11064-006-9185-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11011-008-9118-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038300056", 
              "https://doi.org/10.1007/s11011-008-9118-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1016/s0893-133x(98)00088-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045977517", 
              "https://doi.org/10.1016/s0893-133x(98)00088-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.npp.1300439", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038620067", 
              "https://doi.org/10.1038/sj.npp.1300439"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/35017574", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044051571", 
              "https://doi.org/10.1038/35017574"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.ejcn.1602072", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003095171", 
              "https://doi.org/10.1038/sj.ejcn.1602072"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11064-007-9289-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011540148", 
              "https://doi.org/10.1007/s11064-007-9289-x"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2012-01-24", 
        "datePublishedReg": "2012-01-24", 
        "description": "This paper reviews new drug targets in the treatment of depression and new drug candidates to treat depression. Depression is characterized by aberrations in six intertwined pathways: (1) inflammatory pathways as indicated by increased levels of proinflammatory cytokines, e.g. interleukin-1 (IL-1), IL-6, and tumour necrosis factor \u03b1. (2) Activation of cell-mediated immune pathways as indicated by an increased production of interferon \u03b3 and neopterin. (3) Increased reactive oxygen and nitrogen species and damage by oxidative and nitrosative stress (O&NS), including lipid peroxidation, damage to DNA, proteins and mitochondria. (4) Lowered levels of key antioxidants, such as coenzyme Q10, zinc, vitamin E, glutathione, and glutathione peroxidase. (5) Damage to mitochondria and mitochondrial DNA and reduced activity of respiratory chain enzymes and adenosine triphosphate production. (6) Neuroprogression, which is the progressive process of neurodegeneration, apoptosis, and reduced neurogenesis and neuronal plasticity, phenomena that are probably caused by inflammation and O&NS. Antidepressants tend to normalize the above six pathways. Targeting these pathways has the potential to yield antidepressant effects, e.g. using cytokine antagonists, minocycline, Cox-2 inhibitors, statins, acetylsalicylic acid, ketamine, \u03c93 poly-unsaturated fatty acids, antioxidants, and neurotrophic factors. These six pathways offer new, pathophysiologically guided drug targets suggesting that novel therapies could be developed that target these six pathways simultaneously. Both nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activators and glycogen synthase kinase-3 (GSK-3) inhibitors target the six above-mentioned pathways. GSK-3 inhibitors have antidepressant effects in animal models of depression. Nrf2 activators and GSK-3 inhibitors have the potential to be advanced to phase-2 clinical trials to examine whether they augment the efficacy of antidepressants or are useful as monotherapy.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s10787-011-0111-7", 
        "inLanguage": "en", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1101677", 
            "issn": [
              "0925-4692", 
              "1568-5608"
            ], 
            "name": "Inflammopharmacology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "3", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "20"
          }
        ], 
        "keywords": [
          "GSK-3 inhibitors", 
          "new drug targets", 
          "drug targets", 
          "synthase kinase-3 inhibitors", 
          "respiratory chain enzymes", 
          "nitrosative stress", 
          "mitochondrial DNA", 
          "antidepressant effects", 
          "interleukin-1", 
          "chain enzymes", 
          "tumor necrosis factor \u03b1", 
          "reactive oxygen", 
          "efficacy of antidepressants", 
          "cell-mediated immune", 
          "treatment of depression", 
          "pathway", 
          "immune pathways", 
          "nuclear factor", 
          "necrosis factor \u03b1", 
          "nitrogen species", 
          "COX-2 inhibitors", 
          "Nrf2 activators", 
          "activator", 
          "mitochondria", 
          "key antioxidant", 
          "poly-unsaturated fatty acids", 
          "neuronal plasticity", 
          "DNA", 
          "fatty acids", 
          "neuroprogressive pathways", 
          "cytokine antagonists", 
          "proinflammatory cytokines", 
          "inflammatory pathways", 
          "neurotrophic factor", 
          "IL-6", 
          "clinical trials", 
          "novel therapies", 
          "inhibitors", 
          "new drug candidates", 
          "interferon \u03b3", 
          "animal models", 
          "vitamin E", 
          "reduced activity", 
          "factor \u03b1", 
          "acetylsalicylic acid", 
          "coenzyme Q10", 
          "glutathione peroxidase", 
          "lipid peroxidation", 
          "depression", 
          "target", 
          "antidepressants", 
          "drug candidates", 
          "species", 
          "protein", 
          "apoptosis", 
          "enzyme", 
          "acid", 
          "stress", 
          "plasticity", 
          "progressive process", 
          "production", 
          "neurogenesis", 
          "neurodegeneration", 
          "antioxidants", 
          "activation", 
          "damage", 
          "glutathione", 
          "monotherapy", 
          "peroxidase", 
          "neuroprogression", 
          "neopterin", 
          "statins", 
          "inflammation", 
          "minocycline", 
          "cytokines", 
          "ketamine", 
          "therapy", 
          "antagonist", 
          "trials", 
          "Immune", 
          "aberrations", 
          "efficacy", 
          "peroxidation", 
          "treatment", 
          "levels", 
          "factors", 
          "activity", 
          "potential", 
          "effect", 
          "Q10", 
          "zinc", 
          "candidates", 
          "process", 
          "oxygen", 
          "phenomenon", 
          "model", 
          "paper", 
          "cell-mediated immune pathways", 
          "\u03c93 poly-unsaturated fatty acids", 
          "kinase-3 (GSK-3) inhibitors", 
          "new drug candidates\u2014Nrf2 activators", 
          "drug candidates\u2014Nrf2 activators", 
          "candidates\u2014Nrf2 activators"
        ], 
        "name": "New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates\u2014Nrf2 activators and GSK-3 inhibitors", 
        "pagination": "127-150", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1025174834"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s10787-011-0111-7"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "22271002"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s10787-011-0111-7", 
          "https://app.dimensions.ai/details/publication/pub.1025174834"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2021-12-01T19:28", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_582.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s10787-011-0111-7"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10787-011-0111-7'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10787-011-0111-7'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10787-011-0111-7'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10787-011-0111-7'


     

    This table displays all metadata directly associated to this object as RDF triples.

    408 TRIPLES      22 PREDICATES      177 URIs      134 LITERALS      20 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s10787-011-0111-7 schema:about N1b84e55765a74e5b95653993ea69c21a
    2 N2d985dee66d74a158dba90a04e340209
    3 N588349c2115f4d6092ef7d2fc7cd5583
    4 N6538dfadfe6e47d1af99fa547162f47b
    5 N67d47fcbf5f64ed6a94c516d93ef2eb9
    6 N6a0684f0ee284fee9ff7b83487b0442b
    7 N858462fe8fa24df282b516906d0b2272
    8 N9b8d23afad554d9d9aca442af680d809
    9 Na3a9e087e0584684a700442092bb1904
    10 Nb508cae4b5404f14bdb6576c21658527
    11 Nd7bbd01bebb84d329d632a1b46bd8138
    12 Ne59627841fcf457195fd003ad0b7b90b
    13 Nf40701898bae4425b5836d47c6272b7f
    14 anzsrc-for:11
    15 anzsrc-for:1115
    16 schema:author N7282211cd4d14fc5b07ccfb91118bf41
    17 schema:citation sg:pub.10.1007/978-0-585-37970-8_12
    18 sg:pub.10.1007/978-1-4419-7347-4_3
    19 sg:pub.10.1007/bf02532409
    20 sg:pub.10.1007/s00018-007-7079-x
    21 sg:pub.10.1007/s00134-007-0595-1
    22 sg:pub.10.1007/s00535-008-2266-6
    23 sg:pub.10.1007/s00702-007-0705-9
    24 sg:pub.10.1007/s10863-011-9349-4
    25 sg:pub.10.1007/s11011-008-9118-1
    26 sg:pub.10.1007/s11064-006-9185-9
    27 sg:pub.10.1007/s11064-006-9258-9
    28 sg:pub.10.1007/s11064-007-9289-x
    29 sg:pub.10.1007/s11064-010-0331-z
    30 sg:pub.10.1007/s11064-011-0571-6
    31 sg:pub.10.1007/s12035-011-8181-5
    32 sg:pub.10.1016/s0893-133x(98)00088-8
    33 sg:pub.10.1016/s0893-133x(99)00134-7
    34 sg:pub.10.1016/s1734-1140(09)70084-2
    35 sg:pub.10.1038/35017574
    36 sg:pub.10.1038/aps.2009.72
    37 sg:pub.10.1038/mp.2011.167
    38 sg:pub.10.1038/ni1221
    39 sg:pub.10.1038/nn1069
    40 sg:pub.10.1038/npp.2011.132
    41 sg:pub.10.1038/nrn1555
    42 sg:pub.10.1038/sj.ejcn.1602072
    43 sg:pub.10.1038/sj.mp.4000494
    44 sg:pub.10.1038/sj.mp.4001711
    45 sg:pub.10.1038/sj.mp.4001805
    46 sg:pub.10.1038/sj.npp.1300439
    47 sg:pub.10.1038/sj.npp.1300731
    48 sg:pub.10.1038/sj.npp.1301671
    49 sg:pub.10.1186/1751-0759-2-7
    50 sg:pub.10.2165/00023210-200721010-00001
    51 sg:pub.10.2165/11318640-000000000-00000
    52 schema:datePublished 2012-01-24
    53 schema:datePublishedReg 2012-01-24
    54 schema:description This paper reviews new drug targets in the treatment of depression and new drug candidates to treat depression. Depression is characterized by aberrations in six intertwined pathways: (1) inflammatory pathways as indicated by increased levels of proinflammatory cytokines, e.g. interleukin-1 (IL-1), IL-6, and tumour necrosis factor α. (2) Activation of cell-mediated immune pathways as indicated by an increased production of interferon γ and neopterin. (3) Increased reactive oxygen and nitrogen species and damage by oxidative and nitrosative stress (O&NS), including lipid peroxidation, damage to DNA, proteins and mitochondria. (4) Lowered levels of key antioxidants, such as coenzyme Q10, zinc, vitamin E, glutathione, and glutathione peroxidase. (5) Damage to mitochondria and mitochondrial DNA and reduced activity of respiratory chain enzymes and adenosine triphosphate production. (6) Neuroprogression, which is the progressive process of neurodegeneration, apoptosis, and reduced neurogenesis and neuronal plasticity, phenomena that are probably caused by inflammation and O&NS. Antidepressants tend to normalize the above six pathways. Targeting these pathways has the potential to yield antidepressant effects, e.g. using cytokine antagonists, minocycline, Cox-2 inhibitors, statins, acetylsalicylic acid, ketamine, ω3 poly-unsaturated fatty acids, antioxidants, and neurotrophic factors. These six pathways offer new, pathophysiologically guided drug targets suggesting that novel therapies could be developed that target these six pathways simultaneously. Both nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activators and glycogen synthase kinase-3 (GSK-3) inhibitors target the six above-mentioned pathways. GSK-3 inhibitors have antidepressant effects in animal models of depression. Nrf2 activators and GSK-3 inhibitors have the potential to be advanced to phase-2 clinical trials to examine whether they augment the efficacy of antidepressants or are useful as monotherapy.
    55 schema:genre article
    56 schema:inLanguage en
    57 schema:isAccessibleForFree false
    58 schema:isPartOf N220bb28ada7f46c58113945d9439e72e
    59 N66e33025801944e2ba9da17a7e3ccc54
    60 sg:journal.1101677
    61 schema:keywords COX-2 inhibitors
    62 DNA
    63 GSK-3 inhibitors
    64 IL-6
    65 Immune
    66 Nrf2 activators
    67 Q10
    68 aberrations
    69 acetylsalicylic acid
    70 acid
    71 activation
    72 activator
    73 activity
    74 animal models
    75 antagonist
    76 antidepressant effects
    77 antidepressants
    78 antioxidants
    79 apoptosis
    80 candidates
    81 candidates—Nrf2 activators
    82 cell-mediated immune
    83 cell-mediated immune pathways
    84 chain enzymes
    85 clinical trials
    86 coenzyme Q10
    87 cytokine antagonists
    88 cytokines
    89 damage
    90 depression
    91 drug candidates
    92 drug candidates—Nrf2 activators
    93 drug targets
    94 effect
    95 efficacy
    96 efficacy of antidepressants
    97 enzyme
    98 factor α
    99 factors
    100 fatty acids
    101 glutathione
    102 glutathione peroxidase
    103 immune pathways
    104 inflammation
    105 inflammatory pathways
    106 inhibitors
    107 interferon γ
    108 interleukin-1
    109 ketamine
    110 key antioxidant
    111 kinase-3 (GSK-3) inhibitors
    112 levels
    113 lipid peroxidation
    114 minocycline
    115 mitochondria
    116 mitochondrial DNA
    117 model
    118 monotherapy
    119 necrosis factor α
    120 neopterin
    121 neurodegeneration
    122 neurogenesis
    123 neuronal plasticity
    124 neuroprogression
    125 neuroprogressive pathways
    126 neurotrophic factor
    127 new drug candidates
    128 new drug candidates—Nrf2 activators
    129 new drug targets
    130 nitrogen species
    131 nitrosative stress
    132 novel therapies
    133 nuclear factor
    134 oxygen
    135 paper
    136 pathway
    137 peroxidase
    138 peroxidation
    139 phenomenon
    140 plasticity
    141 poly-unsaturated fatty acids
    142 potential
    143 process
    144 production
    145 progressive process
    146 proinflammatory cytokines
    147 protein
    148 reactive oxygen
    149 reduced activity
    150 respiratory chain enzymes
    151 species
    152 statins
    153 stress
    154 synthase kinase-3 inhibitors
    155 target
    156 therapy
    157 treatment
    158 treatment of depression
    159 trials
    160 tumor necrosis factor α
    161 vitamin E
    162 zinc
    163 ω3 poly-unsaturated fatty acids
    164 schema:name New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors
    165 schema:pagination 127-150
    166 schema:productId N14410d55ca4e42b9889570d54a0a892d
    167 N32c50255be2a4b528c4647fe8406a9b4
    168 N63ca79c8eb8c4a10811e13c7def24fab
    169 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025174834
    170 https://doi.org/10.1007/s10787-011-0111-7
    171 schema:sdDatePublished 2021-12-01T19:28
    172 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    173 schema:sdPublisher N4b93d495087e4beda3cedb8142ea392b
    174 schema:url https://doi.org/10.1007/s10787-011-0111-7
    175 sgo:license sg:explorer/license/
    176 sgo:sdDataset articles
    177 rdf:type schema:ScholarlyArticle
    178 N0b2f9e23d2bf4c3e94349da57476b583 rdf:first sg:person.01163140663.73
    179 rdf:rest N2fab894e943440b29d319685a85b4a48
    180 N14410d55ca4e42b9889570d54a0a892d schema:name pubmed_id
    181 schema:value 22271002
    182 rdf:type schema:PropertyValue
    183 N1b84e55765a74e5b95653993ea69c21a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    184 schema:name Inflammation Mediators
    185 rdf:type schema:DefinedTerm
    186 N220bb28ada7f46c58113945d9439e72e schema:issueNumber 3
    187 rdf:type schema:PublicationIssue
    188 N2d985dee66d74a158dba90a04e340209 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    189 schema:name Glycogen Synthase Kinase 3
    190 rdf:type schema:DefinedTerm
    191 N2fab894e943440b29d319685a85b4a48 rdf:first sg:person.01257261765.73
    192 rdf:rest rdf:nil
    193 N32c50255be2a4b528c4647fe8406a9b4 schema:name doi
    194 schema:value 10.1007/s10787-011-0111-7
    195 rdf:type schema:PropertyValue
    196 N4b93d495087e4beda3cedb8142ea392b schema:name Springer Nature - SN SciGraph project
    197 rdf:type schema:Organization
    198 N588349c2115f4d6092ef7d2fc7cd5583 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    199 schema:name Antioxidants
    200 rdf:type schema:DefinedTerm
    201 N63ca79c8eb8c4a10811e13c7def24fab schema:name dimensions_id
    202 schema:value pub.1025174834
    203 rdf:type schema:PropertyValue
    204 N6538dfadfe6e47d1af99fa547162f47b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    205 schema:name Mitochondria
    206 rdf:type schema:DefinedTerm
    207 N66e33025801944e2ba9da17a7e3ccc54 schema:volumeNumber 20
    208 rdf:type schema:PublicationVolume
    209 N67d47fcbf5f64ed6a94c516d93ef2eb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    210 schema:name Oxidative Stress
    211 rdf:type schema:DefinedTerm
    212 N6a0684f0ee284fee9ff7b83487b0442b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    213 schema:name Disease Progression
    214 rdf:type schema:DefinedTerm
    215 N7282211cd4d14fc5b07ccfb91118bf41 rdf:first sg:person.012515577577.25
    216 rdf:rest Nd0bcada5012140799ab4dcbee60c25be
    217 N858462fe8fa24df282b516906d0b2272 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    218 schema:name NF-E2-Related Factor 2
    219 rdf:type schema:DefinedTerm
    220 N8a6a361d395f45738ab587d090f64996 rdf:first sg:person.0772116134.66
    221 rdf:rest N0b2f9e23d2bf4c3e94349da57476b583
    222 N9b8d23afad554d9d9aca442af680d809 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    223 schema:name Drug Delivery Systems
    224 rdf:type schema:DefinedTerm
    225 Na3a9e087e0584684a700442092bb1904 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    226 schema:name Humans
    227 rdf:type schema:DefinedTerm
    228 Nb508cae4b5404f14bdb6576c21658527 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    229 schema:name Immunity, Cellular
    230 rdf:type schema:DefinedTerm
    231 Nd0bcada5012140799ab4dcbee60c25be rdf:first sg:person.0575473643.42
    232 rdf:rest Ne61ee39e3b9f491a822de605a192a88e
    233 Nd7bbd01bebb84d329d632a1b46bd8138 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    234 schema:name Depression
    235 rdf:type schema:DefinedTerm
    236 Ne59627841fcf457195fd003ad0b7b90b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    237 schema:name Nitrosation
    238 rdf:type schema:DefinedTerm
    239 Ne61ee39e3b9f491a822de605a192a88e rdf:first sg:person.01255705374.56
    240 rdf:rest N8a6a361d395f45738ab587d090f64996
    241 Nf40701898bae4425b5836d47c6272b7f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    242 schema:name Animals
    243 rdf:type schema:DefinedTerm
    244 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    245 schema:name Medical and Health Sciences
    246 rdf:type schema:DefinedTerm
    247 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
    248 schema:name Pharmacology and Pharmaceutical Sciences
    249 rdf:type schema:DefinedTerm
    250 sg:journal.1101677 schema:issn 0925-4692
    251 1568-5608
    252 schema:name Inflammopharmacology
    253 schema:publisher Springer Nature
    254 rdf:type schema:Periodical
    255 sg:person.01163140663.73 schema:affiliation grid-institutes:grid.5522.0
    256 schema:familyName Nowak
    257 schema:givenName Gabriel
    258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163140663.73
    259 rdf:type schema:Person
    260 sg:person.012515577577.25 schema:affiliation grid-institutes:None
    261 schema:familyName Maes
    262 schema:givenName Michael
    263 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012515577577.25
    264 rdf:type schema:Person
    265 sg:person.01255705374.56 schema:affiliation grid-institutes:None
    266 schema:familyName Medina
    267 schema:givenName Miguel
    268 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255705374.56
    269 rdf:type schema:Person
    270 sg:person.01257261765.73 schema:affiliation grid-institutes:grid.415325.4
    271 schema:familyName Berk
    272 schema:givenName Michael
    273 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257261765.73
    274 rdf:type schema:Person
    275 sg:person.0575473643.42 schema:affiliation grid-institutes:grid.411798.2
    276 schema:familyName Fišar
    277 schema:givenName Zdenĕk
    278 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0575473643.42
    279 rdf:type schema:Person
    280 sg:person.0772116134.66 schema:affiliation grid-institutes:grid.10373.36
    281 schema:familyName Scapagnini
    282 schema:givenName Giovanni
    283 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772116134.66
    284 rdf:type schema:Person
    285 sg:pub.10.1007/978-0-585-37970-8_12 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051824596
    286 https://doi.org/10.1007/978-0-585-37970-8_12
    287 rdf:type schema:CreativeWork
    288 sg:pub.10.1007/978-1-4419-7347-4_3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041698027
    289 https://doi.org/10.1007/978-1-4419-7347-4_3
    290 rdf:type schema:CreativeWork
    291 sg:pub.10.1007/bf02532409 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012282090
    292 https://doi.org/10.1007/bf02532409
    293 rdf:type schema:CreativeWork
    294 sg:pub.10.1007/s00018-007-7079-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1003536562
    295 https://doi.org/10.1007/s00018-007-7079-x
    296 rdf:type schema:CreativeWork
    297 sg:pub.10.1007/s00134-007-0595-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002017190
    298 https://doi.org/10.1007/s00134-007-0595-1
    299 rdf:type schema:CreativeWork
    300 sg:pub.10.1007/s00535-008-2266-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048185237
    301 https://doi.org/10.1007/s00535-008-2266-6
    302 rdf:type schema:CreativeWork
    303 sg:pub.10.1007/s00702-007-0705-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025211480
    304 https://doi.org/10.1007/s00702-007-0705-9
    305 rdf:type schema:CreativeWork
    306 sg:pub.10.1007/s10863-011-9349-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008210266
    307 https://doi.org/10.1007/s10863-011-9349-4
    308 rdf:type schema:CreativeWork
    309 sg:pub.10.1007/s11011-008-9118-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038300056
    310 https://doi.org/10.1007/s11011-008-9118-1
    311 rdf:type schema:CreativeWork
    312 sg:pub.10.1007/s11064-006-9185-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045444984
    313 https://doi.org/10.1007/s11064-006-9185-9
    314 rdf:type schema:CreativeWork
    315 sg:pub.10.1007/s11064-006-9258-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005583383
    316 https://doi.org/10.1007/s11064-006-9258-9
    317 rdf:type schema:CreativeWork
    318 sg:pub.10.1007/s11064-007-9289-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1011540148
    319 https://doi.org/10.1007/s11064-007-9289-x
    320 rdf:type schema:CreativeWork
    321 sg:pub.10.1007/s11064-010-0331-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1046900819
    322 https://doi.org/10.1007/s11064-010-0331-z
    323 rdf:type schema:CreativeWork
    324 sg:pub.10.1007/s11064-011-0571-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043113915
    325 https://doi.org/10.1007/s11064-011-0571-6
    326 rdf:type schema:CreativeWork
    327 sg:pub.10.1007/s12035-011-8181-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034451897
    328 https://doi.org/10.1007/s12035-011-8181-5
    329 rdf:type schema:CreativeWork
    330 sg:pub.10.1016/s0893-133x(98)00088-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045977517
    331 https://doi.org/10.1016/s0893-133x(98)00088-8
    332 rdf:type schema:CreativeWork
    333 sg:pub.10.1016/s0893-133x(99)00134-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007198609
    334 https://doi.org/10.1016/s0893-133x(99)00134-7
    335 rdf:type schema:CreativeWork
    336 sg:pub.10.1016/s1734-1140(09)70084-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021803075
    337 https://doi.org/10.1016/s1734-1140(09)70084-2
    338 rdf:type schema:CreativeWork
    339 sg:pub.10.1038/35017574 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044051571
    340 https://doi.org/10.1038/35017574
    341 rdf:type schema:CreativeWork
    342 sg:pub.10.1038/aps.2009.72 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008490105
    343 https://doi.org/10.1038/aps.2009.72
    344 rdf:type schema:CreativeWork
    345 sg:pub.10.1038/mp.2011.167 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023005430
    346 https://doi.org/10.1038/mp.2011.167
    347 rdf:type schema:CreativeWork
    348 sg:pub.10.1038/ni1221 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034883080
    349 https://doi.org/10.1038/ni1221
    350 rdf:type schema:CreativeWork
    351 sg:pub.10.1038/nn1069 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017871287
    352 https://doi.org/10.1038/nn1069
    353 rdf:type schema:CreativeWork
    354 sg:pub.10.1038/npp.2011.132 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045237385
    355 https://doi.org/10.1038/npp.2011.132
    356 rdf:type schema:CreativeWork
    357 sg:pub.10.1038/nrn1555 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020167313
    358 https://doi.org/10.1038/nrn1555
    359 rdf:type schema:CreativeWork
    360 sg:pub.10.1038/sj.ejcn.1602072 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003095171
    361 https://doi.org/10.1038/sj.ejcn.1602072
    362 rdf:type schema:CreativeWork
    363 sg:pub.10.1038/sj.mp.4000494 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024877376
    364 https://doi.org/10.1038/sj.mp.4000494
    365 rdf:type schema:CreativeWork
    366 sg:pub.10.1038/sj.mp.4001711 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047482815
    367 https://doi.org/10.1038/sj.mp.4001711
    368 rdf:type schema:CreativeWork
    369 sg:pub.10.1038/sj.mp.4001805 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024644463
    370 https://doi.org/10.1038/sj.mp.4001805
    371 rdf:type schema:CreativeWork
    372 sg:pub.10.1038/sj.npp.1300439 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038620067
    373 https://doi.org/10.1038/sj.npp.1300439
    374 rdf:type schema:CreativeWork
    375 sg:pub.10.1038/sj.npp.1300731 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046403978
    376 https://doi.org/10.1038/sj.npp.1300731
    377 rdf:type schema:CreativeWork
    378 sg:pub.10.1038/sj.npp.1301671 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049219951
    379 https://doi.org/10.1038/sj.npp.1301671
    380 rdf:type schema:CreativeWork
    381 sg:pub.10.1186/1751-0759-2-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017318313
    382 https://doi.org/10.1186/1751-0759-2-7
    383 rdf:type schema:CreativeWork
    384 sg:pub.10.2165/00023210-200721010-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022297507
    385 https://doi.org/10.2165/00023210-200721010-00001
    386 rdf:type schema:CreativeWork
    387 sg:pub.10.2165/11318640-000000000-00000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048198006
    388 https://doi.org/10.2165/11318640-000000000-00000
    389 rdf:type schema:CreativeWork
    390 grid-institutes:None schema:alternateName Maes Clinics@TRIA, 998 Rimklongsamsen Road, 10310, Bangkok, Thailand
    391 Noscira, Tres Cantos, Spain
    392 schema:name Maes Clinics@TRIA, 998 Rimklongsamsen Road, 10310, Bangkok, Thailand
    393 Noscira, Tres Cantos, Spain
    394 rdf:type schema:Organization
    395 grid-institutes:grid.10373.36 schema:alternateName Department of Health Sciences, University of Molise, Campobasso, Italy
    396 schema:name Department of Health Sciences, University of Molise, Campobasso, Italy
    397 rdf:type schema:Organization
    398 grid-institutes:grid.411798.2 schema:alternateName Department of Psychiatry, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic
    399 schema:name Department of Psychiatry, First Faculty of Medicine, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic
    400 rdf:type schema:Organization
    401 grid-institutes:grid.415325.4 schema:alternateName Mental Health Research Institute, Melbourne, Australia
    402 schema:name Department of Clinical and Biomedical Sciences, The University of Melbourne, Melbourne, VIC, Australia
    403 Mental Health Research Institute, Melbourne, Australia
    404 Orygen Research Centre, Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, Australia
    405 rdf:type schema:Organization
    406 grid-institutes:grid.5522.0 schema:alternateName Department of Pharmacobiology, Jagiellonian University Medical College, Institute of Pharmacology PAS, Krakow, Poland
    407 schema:name Department of Pharmacobiology, Jagiellonian University Medical College, Institute of Pharmacology PAS, Krakow, Poland
    408 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...